Related Experiment Video
Updated: Sep 16, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample
Anne Kever1,2, Cecilia Meza1,3, Anthony Feinstein1,3
1Division of Neurology, Department of Medicine, Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Background:
Cannabis is commonly used in persons with MS (pwMS) for symptom relief. Previous studies investigating the effects of cannabis on objective cognitive functioning in MS have yielded mixed results.
Aim:
To examine associations of recreational cannabis use with objective cognitive performance in a large, consecutive clinical sample of pwMS.
Methods:
In a cross-sectional study, 847 pwMS provided information on cannabis consumption and were administered the Minimal Assessment of Cognitive Function in MS (MACFIMS) battery, assessing memory, executive function, language, and processing speed. Cognitive performance of cannabis users (N = 254) and nonusers (N = 593) was compared by means of a one-way MANOVA. Multiple linear regressions then examined whether cannabis use independently predicted cognitive test results.
Results:
A significant effect of cannabis use on cognitive performance was observed, F(11, 692) = 1.955, p = 0.030, Wilks λ = 0.970, with users performing significantly poorer than nonusers on the SDMT [F(1, 703) = 6.099, p = 0.014]. Regression models, taking into account covariates (age, education, disease duration, anxiety, and fatigue) revealed that cannabis independently predicted performance on the SDMT, PASAT-3, and PASAT-2, all p < 0.001. Models explained 15.8%, 7.1%, and 8.7% of variance, respectively.
Conclusion:
This cross-sectional study provides evidence that cannabis use is associated with poorer processing speed and working memory in pwMS, thereby presenting a possible additional risk factor for cognitive impairment. This finding takes on added concern in light of cannabis use increasing with its legalization, and the worldwide increase of cannabis potency.
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

